Abstract
Influenza is an infectious disease which results in numerous epidemics every year. At present, neuraminidase is regarded, as the key therapeutic target against influenza and several well-known neuraminidase inhibitors are widely used as anti-influenza drugs. Combined computational methods including 3D-QSAR and molecular docking were applied to explore the structural–activity relationship with Xu’s compounds as the data set. Ten epigoitrin derivatives were then designed based on the computational results and they displayed 11.1–85.5 μM inhibitory potencies against neuraminidase in the in vitro biological evaluation. The combined computational studies did not only present the structural–activity relationship of Xu’s inhibitors, but also guide the designation of epigoitrin derivatives as novel neuraminidase inhibitors.
Graphical abstract
Similar content being viewed by others
References
Mendel DB, Tai CY, Escarpe PA, Li W, Sidwell RW, Huffman JH, Sweet C, Jakeman KJ, Merson J, Lacy SA, Lew W, Williams MA, Zhang L, Chen MS, Bischofberger N, Kim CU (1998) Antimicrob Agents Chemother 42:640
Girard MP, Tam JS, Assossou OM, Kieny MP (2010) Vaccine 28:4895
Uyeki TM, Cox NJ (2013) N Engl J Med 368:1862
Stevens J, Blixt O, Chen LM, Donis RO, Paulson JC, Wilson IA (2008) J Mol Biol 381:1382
Russell RJ, Haire LF, Stevens DJ, Collins PJ, Lin YP, Blackburn GM, Hay AJ, Gamblin SJ, Skehel JJ (2006) Nature 443:45
Babu YS, Chand P, Bantia S, Kotian P, Dehghani A, El- Kattan Y, Lin TH, Hutchison TL, Elliott AJ, Parker CD, Ananth SL, Horn LL, Laver GW, Montgomery JA (2000) J Med Chem 43:3482
Cheng LP, Huang XY, Wang Z, Kai ZP, Wu FH (2014) Monatsh Chem 145:1213
Von Itzstein M (2007) Nat Rev Drug Discov 6:967
Von Itzstein M, Wu WY, Kok GB, Pegg MS, Dyason JC, Jin B, Van Phan T, Smythe ML, White HF, Oliver SW, Colman PM, Varghese JN, Ryan DM, Woods JM, Bethell RC, Hotham VJ, Cameron JM, Penn CR (1993) Nature 363:418
Kale RR, Mukundan H, Price DN, Harris JF, Lewallen DM, Swanson BI, Schmidt JG, Iyer SS (2008) J Am Chem Soc 130:8169
Takano R, Kiso M, Igarashi M, Le QM, Sekijima M, Ito K, Takada A, Kawaoka Y (2013) J Infect Dis 207:89
Rakers C, Schwerdtfeger SM, Mortier J, Duwe S, Wolff T, Wolber G, Melzig MF (2014) Bioorg Med Chem Lett 24:4312
Dao TT, Dang TT, Nguyen PH, Kim E, Thuong PT, Oh WK (2012) Bioorg Med Chem Lett 22:3688
Grienke U, Schmidtke M, Kirchmair J, Pfarr K, Wutzler P, Durrwald R, Wolber G, Liedl KR, Stuppner H, Rollinger J (2010) M J Med Chem 53:778
Luo Y, Wang L (2017) Curr Pharm Design 23:4321
Naik PK, Santoshi S, Birmani A (2009) Int Electron J Mol De 8:42
Ding M, Yin Y, Wu FH, Cui JX, Zhou H, Sun GF, Jiang Y, Feng YB (2015) Bioorg Med Chem 23:2505
Cui JX, Ding M, Deng W, Yin Y, Wang ZH, Zhou H, Sun GF, Jiang Y, Feng YB (2015) Bioorg Med Chem 23:7464
Zhao Z, Cui JX, Yin Y, Zhang H, Liu YC, Zeng R, Fang C, Kai ZP, Wang ZH, Wu FH (2016) Chin J Chem 34:801
Duan YB, Yin Y, Meng FL, Zhao LH, Liu YK, Yuan Z, Feng YB (2017) Chem J Chin Univ 38:1568
Zhang QY, Yang JY, Liang K, Feng LL, Li SP, Wan J, Xu X, Yang GF, Liu DL, Yang S (2008) J Chem Inf Model 48:1802
Cramer RD III, Patterson DE, Bunce JD (1988) J Am Chem Soc 110:5959
Xie YC, Huang B, Yu KX, Shi FY, Liu TQ, Xu WF (2013) Bioorg Med Chem Lett 23:3556
Stahle L, Wold S (1987) J Chemometr 1:185
Stanton DT (2012) Curr Comput Aided Drug Des 8:107
Golbraikh A, Tropsha A (2002) J Mol Graph Model 20:269
Zhou W, Zhao XJ (2013) Am J Chin Med 41:743
Xiao P, Ye WY, Chen JW, Li X (2016) J Tradit Chin Med 36:369
Zhang SJ, Liu MH, Li HB, Jiang L, Luo Y, Sun Q (2013) Chin J New Drugs 22:1083
Tong WQ, Lach JL, Chin TF, Guillory JK (1991) Pharm Res 8:1307
Gasteiger J, Marsili M (1980) Tetrahedron 36:3219
Wang Y, Yu M, Wang XN, Zhang X, Wang XZ, Fang XX (2015) RSC Adv 5:64937
Potier M, Mameli L, Belisle M, Dallaire L, Melancon SB (1979) Anal Biochem 94:287
Acknowledgements
The work was supported by National Natural Science Foundation of China (Grant No. 21502117), Shanghai Municipal Education Commission (Plateau Discipline Construction Program), and the Collaboration Innovation Foundation of Shanghai Institute of Technology (No. XTCX2016-3). Support from Prof. Gang Zhao and Prof. Guanjun Wang was also greatly appreciated.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Meng, F., Yin, Y., Lu, C. et al. Design, synthesis, and in vitro evaluation of epigoitrin derivatives as neuraminidase inhibitors. Monatsh Chem 149, 2037–2046 (2018). https://doi.org/10.1007/s00706-018-2245-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-018-2245-4